Showing results (701-710 of 980) with videos related to
Sort By:
Pageof 98
Current Drug Safety|April 5, 2026
Itraconazole-Induced Motor Sensory Polyneuropathy in a Young Indian Male: An Unusual CaseJitendra Singh, Pooja Chaurasiya, Anju Dinkar, et al.Current Drug Safety|April 5, 2026
Prospective Assessment of Body Composition Changes with Sodium Glucose Transporters 2 (SGLT2) Inhibitors in Type 2 Diabetes Mellitus Using Bioelectrical Impedance AnalysisBharti Bhandari, Preeti Kaliramana, Prerna Agarwal, et al.Current Drug Safety|April 6, 2026
Assessment of Iguratimod's Efficacy and Safety in Rheumatoid Arthritis: A Prospective, Open-Label StudyB Banupriya, Sulthan Al Rashid, Preetha SelvaCurrent Drug Safety|June 2, 2026
Pharmacovigilance Assessment of Thrombotic Adverse Events Linked to GLP-1 Receptor Agonists: Analysis of FAERS Reports from 2020-2025Eman M Mansory, Osman O RadhwiCurrent Drug Safety|May 19, 2026
Descriptive Analysis of Adverse Drug Events of Three mTOR Inhibitors Using WHO-VigiAccessPrerna Bhati, Prakash Haloi, Havagiray R ChitmeCurrent Drug Safety|May 15, 2026
Liraglutide Causing Pancreatitis in an Indian Obese Female: A Case Report and Review of the LiteratureJitendra Singh, Anju Dinkar, Rajeev Verma, et al.Current Drug Safety|June 9, 2018
Denosumab-induced Normocalcemic Hyperparathyroidism in a Woman with Postmenopausal Osteoporosis and Normal Renal FunctionElias E MazokopakisCurrent Drug Safety|April 29, 2011
PTH treatment in hypoparathyroidismTanja Sikjaer, Lars Rejnmark, Leif MosekildeCurrent Drug Safety|June 15, 2023
Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case ReportImen Aouintia, Wiem Daly, Ghozlane Lakhoua, et al.Current Drug Safety|June 29, 2026
Explainable Artificial Intelligence in Pharmacovigilance and Drug Safety: A Systematic Review of Enhancing Transparency and Regulatory AcceptanceVirendra S Gomase, Shenbagavel Vairachilai, Rupali Sharma, et al.Pageof 98